Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LADX | Stock Appreciation Right | Award | $0 | +50K | $0.00 | 50K | Dec 15, 2021 | Common Stock | 50K | $0.45 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The purpose of this Amendment is to report the stock appreciation rights granted to the reporting person on December 15, 2021, which were inadvertently excluded from the original Form 4. The stock appreciation rights will vest in full on the first anniversary of December 15, 2021, provided that the reporting person is still a service provider of CytRx Corporation on such date. |
F2 | No expiration date. |